miR-28-5p targets MTSS1 to regulate cell proliferation and apoptosis in esophageal cancer

Liang Zhang,Xin Wang,Xin Liu,Mingyue Lv,Erdong Shen,Guolian Zhu,Zhe Sun

DOI: https://doi.org/10.1093/abbs/gmaa059

IF: 3.7

2020-07-09

Acta Biochimica et Biophysica Sinica

Abstract:Abstract Esophageal cancer (EC) is one of the most common aggressive malignant diseases worldwide. miR-28-5p plays important regulatory roles in many cancers including human EC. However, the molecular mechanism and potential role of miR-28-5p in EC remain uncertain. In this study, qRT-PCR and western blot analysis revealed that miR-28-5p expression was up-regulated and metastasis suppressor-1 (MTSS1) was down-regulated in EC tissues relative to matched para-cancer tissues. Cell counting kit-8 (CCK-8) assay demonstrated that miR-28-5p mimics increased cell viability, and miR-28-5p inhibitor decreased it. Flow cytometry (FCM) assay indicated that miR-28-5p mimics promoted cell cycle entry, while miR-28-5p inhibitor reduced it and induced cell apoptosis. Moreover, miR-28-5p mimics up-regulated the expressions of cyclin A, cyclin dependent kinase 2 (CDK2), cyclin D1, and cyclin E but down-regulated the expressions of cleaved caspase-3 and cleaved caspase-9, which was abolished by miR-28-5p inhibitor. Furthermore, luciferase reporter assay verified that miR-28-5p directly targeted MTSS1 3′UTR and down-regulated its expression. MTSS1 overexpression in TE-1 cells inhibited cell proliferation and promoted apoptosis induced by miR-28-5p mimics, whereas silencing of MTSS1 reversed cell progression induced by miR-28-5p inhibitor. We also demonstrated that miR-28-5p could promote esophageal tumor formation in vivo. Hematoxylin–eosin staining, immunohistochemistry, and TUNEL assays confirmed that miR-28-5p antagomir inhibited cell growth and accelerated apoptosis. Our results suggest that miR-28-5p may induce cell proliferation and suppress apoptosis to promote EC tumor formation via decreasing MTSS1 expression. Thus, miR-28-5p may be a potential target for human EC therapy.

biochemistry & molecular biology,biophysics

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of miR - 28 - 5p in esophageal cancer (Esophageal Cancer, EC) and its molecular mechanism. Specifically, researchers want to know whether miR - 28 - 5p regulates cell proliferation and apoptosis by targeting MTSS1, thereby affecting the development of esophageal cancer. Through this research, they hope to reveal the functional relationship between miR - 28 - 5p and MTSS1 and evaluate the possibility of miR - 28 - 5p as a potential target for the treatment of human esophageal cancer.

### Research Background
Esophageal cancer is a highly malignant tumor and is the sixth leading cause of cancer death worldwide. Currently, most esophageal cancer patients receive extensive treatments including chemotherapy, chemoradiotherapy, and surgical resection. However, due to the lack of effective early - diagnosis methods, most patients are diagnosed in the middle - and - late stages, resulting in poor prognosis and high mortality. Therefore, it is extremely urgent to study the molecular mechanisms in the development and progression of esophageal cancer and explore possible treatment targets.

### Research Objectives
- **Explore the expression of miR - 28 - 5p in esophageal cancer**: Study the expression level of miR - 28 - 5p in esophageal cancer tissues and compare it with that in normal tissues.
- **Analyze the impact of miR - 28 - 5p on cell proliferation and apoptosis**: Verify the specific effects of miR - 28 - 5p on the proliferation and apoptosis of esophageal cancer cells through cell experiments.
- **Determine the target gene of miR - 28 - 5p**: Through bioinformatics prediction and experimental verification, confirm whether MTSS1 is the direct target gene of miR - 28 - 5p.
- **Evaluate the role of miR - 28 - 5p in vivo**: Verify the impact of miR - 28 - 5p on esophageal cancer tumor formation in vivo through animal experiments.

### Main Findings
- **miR - 28 - 5p is highly expressed in esophageal cancer tissues, while MTSS1 is lowly expressed**: Through qRT - PCR and Western Blot analysis, researchers found that the expression of miR - 28 - 5p in esophageal cancer tissues was significantly higher than that in normal tissues, while the expression of MTSS1 was significantly decreased.
- **miR - 28 - 5p promotes cell proliferation**: Through CCK - 8 experiments and flow cytometry (FCM), researchers found that miR - 28 - 5p mimics could significantly increase cell viability and promote the cell cycle to enter the S phase from the G1 phase.
- **miR - 28 - 5p inhibits cell apoptosis**: Through FCM and Western Blot analysis, researchers found that miR - 28 - 5p mimics could down - regulate the expressions of cleaved caspase - 3 and cleaved caspase - 9, thereby inhibiting cell apoptosis.
- **MTSS1 is the direct target gene of miR - 28 - 5p**: Through luciferase reporter gene experiments, researchers confirmed that miR - 28 - 5p could directly target the 3'UTR region of MTSS1 and down - regulate its expression.
- **miR - 28 - 5p promotes tumor formation in vivo**: Through nude mouse experiments, researchers found that injecting miR - 28 - 5p antagonists could significantly reduce tumor volume, decrease cell proliferation and promote cell apoptosis.

### Conclusion
This research shows that miR - 28 - 5p promotes the proliferation of esophageal cancer cells and inhibits cell apoptosis by down - regulating the expression of MTSS1, thus playing an important role in the development of esophageal cancer. Therefore, miR - 28 - 5p may be a potential target for the treatment of esophageal cancer.